Brigole, Yricka Yve .
HRN: 26-59-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2025
CEFUROXIME 750MG (VIAL)
02/12/2025
02/19/2025
IV
750
Q8
Fracture Closed Complete Supracomdylar Humerus
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes